Vibegron for children with nerve bladder using intermittent catheter
Part of Brain & nervous system, Cancer, Genetic & congenital, Immune system & allergy, Infections, Injuries & trauma clinical trials.
This study tests how well and how safely vibegron works long-term in children (ages 2 to under 18) with a nerve-related bladder condition, who regularly use intermittent catheterization. It also tracks how the body processes the medicine and whether it helps bladder control over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 2 and under 18 years old, and you weigh at least 11 kg.
- You have a diagnosed nerve bladder problem (NDO) such as spina bifida/tethered cord, or NDO after spinal cord injury/surgery (at least 6 months ago), or after transverse myelitis (diagnosed at least 12 months ago).
- You do intermittent catheterization (CIC) at least 3 times in 24 hours, including a catheter before bedtime, for at least 4 weeks before screening.
- You do NOT have certain other conditions or situations (like cerebral palsy, uncontrolled epilepsy, diabetes insipidus, or stage 2 high blood pressure).
- You have not had certain bladder procedures or therapies recently (for example, botulinum toxin in the last 9 months, or an indwelling catheter in the last 4 weeks).
- You can pause (“wash out”) other NDO medications if needed for the study, as directed by the team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gene therapy called EG110A for people with overactive bladders due to spinal cord injury. It aims to reduce urinary incontinence and may offer an option if other treatments haven't worked well.
This trial tests if a treatment that uses mild electrical pulses near the ankle (posterior tibial nerve stimulation) is safe and effective for children ages 5 to 21 with overactive bladder (OAB) that hasn't gotten better with standard treatments like behavioral therapy or medication.
This study tests a non-invasive treatment called transcutaneous tibial nerve stimulation (TTNS) for children with overactive bladder (OAB). The goal is to see if it can help reduce frequent, urgent urination by using mild electrical pulses near the ankle.
This trial compares two treatments for kids with overactive bladder: oxybutynin medicine and a painless nerve stimulation device. It aims to find which works better for reducing frequent, urgent, or leaky urination and nighttime accidents.
This trial tests a new device called the NeuroGyn Genital Neuromodulation System to treat overactive bladder (OAB). It's for people who have already tried simpler treatments and had a good response to a test stimulation.
This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.
Hear when a new Neurogenic Detrusor Overactivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.